View Older Stories View More Recent Stories

Oct 21, 2019 09:58AM Veracyte (VCYT) Announces New Data Showing Envisia Genomic Classifier Improves IPF Diagnosis
Oct 21, 2019 09:57AM Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis
Oct 8, 2019 04:30PM Veracyte to Release Third Quarter 2019 Financial Results and Business Progress on October 22, 2019
Oct 7, 2019 08:03AM Veracyte (VCYT) to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST
Oct 7, 2019 08:00AM Veracyte to Announce New Clinical Data for First Noninvasive Nasal Swab Test to Target Early Lung Cancer Detection at CHEST Annual Meeting 2019
Sep 11, 2019 11:04AM Veracyte Announces Publication of Clinical and Analytical Validation Data for Afirma Xpression Atlas
Sep 3, 2019 08:16AM Veracyte (VCYT) Reports Publication of New Study Characterizing Gene Alterations in Thyroid Cancer
Sep 3, 2019 08:15AM Veracyte Announces Publication of New Study Characterizing Gene Alterations in Thyroid Cancer
Aug 28, 2019 04:15PM Veracyte to Present at Upcoming Investor Conferences
Jul 30, 2019 04:15PM Veracyte Announces Second Quarter 2019 Financial Results
Jul 1, 2019 08:00AM Veracyte Names Keith Kennedy Chief Operating Officer and Chief Financial Officer
Jun 27, 2019 04:15PM Veracyte to Release Second Quarter 2019 Financial Results on July 30, 2019
Jun 26, 2019 04:15PM Veracyte Announces Next-Generation Percepta Genomic Sequencing Classifier Now Available to Physicians for Improved Lung Cancer Diagnosis
Jun 24, 2019 08:30AM Veracyte Named a San Francisco Bay Area “Top Workplace” For Sixth Consecutive Year
Jun 17, 2019 08:34AM Veracyte (VCYT) Reports Publication of Data Detailing Clinical Utility of RNA Sequencing-Based Testing
Jun 17, 2019 08:30AM Veracyte Announces New Article Published in Cancer Cytopathology Detailing Clinical Utility of Its RNA Sequencing-Based Testing for Thyroid Cancer Diagnosis and Treatment
Jun 10, 2019 04:15PM Veracyte Announces New Publication of Data Demonstrating Real-World Performance of the Afirma GSC in Thyroid Cancer Diagnosis
Jun 1, 2019 02:15PM Veracyte Announces New Data Showing Potential of Afirma Genomic Test to Guide Targeted Treatment for Medullary Thyroid Cancer Concurrent with Diagnosis
May 29, 2019 04:20PM Veracyte Announces Participation in Two Upcoming Investor Conferences
May 23, 2019 08:00AM Veracyte Announces New Data Demonstrating Afirma Xpression Atlas’s Potential to Inform Treatment Selection for Patients with Medullary Thyroid Cancer to Be Presented at 2019 ASCO Annual Meeting
May 20, 2019 08:08AM Veracyte (VCYT) Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis
May 20, 2019 08:00AM Veracyte Unveils Next-Generation Percepta Genomic Sequencing Classifier for Improved Lung Cancer Diagnosis
May 14, 2019 08:30AM Veracyte Names Sangeeta Bhorade, M.D., Medical Director of Pulmonology
May 9, 2019 04:20PM Veracyte to Present at the UBS Global Healthcare Conference
Apr 30, 2019 04:15PM Veracyte Announces First Quarter 2019 Financial Results
Apr 22, 2019 04:17PM Veracyte (VCYT) Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State
Apr 22, 2019 04:15PM Veracyte Receives Regulatory Authorization to Offer Envisia Genomic Classifier for Patients in New York State
Apr 22, 2019 08:30AM Veracyte Names Alfred Bowie, Jr., Ph.D. as Vice President, Corporate and Business Development
Apr 8, 2019 07:31AM Veracyte (VCYT) Announces Publication Highlighting Afirma GSC’s Ability to Rule Out Cancer in Thyroid Nodule Subtype
Apr 8, 2019 07:30AM Veracyte Announces Publication Highlighting Afirma GSC’s Ability to Rule Out Cancer in Challenging Thyroid Nodule Subtype
Apr 3, 2019 08:30AM Veracyte to Release First Quarter 2019 Financial Results on April 30, 2019
Apr 1, 2019 06:46PM Veracyte Announces Data Published in The Lancet Respiratory Medicine Demonstrate that the Envisia Genomic Classifier Improves Diagnosis of IPF
Mar 28, 2019 04:15PM Veracyte Announces Participation in the 18th Annual Needham Healthcare Conference
Mar 25, 2019 04:15PM Veracyte Announces New Afirma Xpression Atlas Data that Advance Genomic Understanding of Medullary Thyroid Cancer
Mar 19, 2019 07:30AM Veracyte Announces Sponsorship of the Climb to Fight Cancer’s Team Kilimanjaro Expedition
Mar 18, 2019 07:30AM Veracyte Announces New Afirma Xpression Atlas Data on Medullary Thyroid Cancer to Be Presented at ENDO 2019
Mar 4, 2019 08:36AM Veracyte (VCYT) Receives Final Medicare Coverage Policy for Envisia Genomic Classifier
Mar 4, 2019 08:30AM Veracyte Receives Final Medicare Coverage Policy for Envisia Genomic Classifier
Feb 25, 2019 04:15PM Veracyte Announces Fourth Quarter and Full-Year 2018 Financial Results and Provides 2019 Financial Outlook
Feb 20, 2019 04:20PM Veracyte Announces Participation in Upcoming Investor Conferences
Jan 28, 2019 04:20PM Veracyte to Release Fourth Quarter and Full-Year 2018 Financial Results February 25, 2019
Jan 9, 2019 04:30PM Veracyte to Present at the 21st Annual Needham Growth Conference
Jan 3, 2019 07:12AM Veracyte (VCYT) Reports Strategic Collaboration with Johnson & Johnson (JNJ) Innovation in Battle Against Lung Cancer
Jan 3, 2019 07:00AM Veracyte Announces Strategic Collaboration with Johnson & Johnson Innovation in Battle Against Lung Cancer
Jan 2, 2019 05:54PM Veracyte to Present at the 37th Annual J.P. Morgan Healthcare Conference
Dec 5, 2018 07:30AM Veracyte Announces Expansion of Envisia Genomic Classifier Early Access Program
Nov 9, 2018 08:30AM Veracyte to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
Nov 8, 2018 04:24PM Veracyte Announces Publication of Data Demonstrating “Real World” Performance of Afirma GSC in Thyroid Cancer Diagnosis
Oct 29, 2018 04:05PM Veracyte Announces Third Quarter 2018 Financial Results
Oct 15, 2018 04:20PM Veracyte to Host Conference Call and Webcast to Discuss Third Quarter 2018 Financial Results on Monday, October 29, 2018
View More Recent Stories View Older Stories